Bid Publish Date
17-Mar-2025, 2:19 pm
Bid End Date
07-Apr-2025, 3:00 pm
EMD
₹1,621
Location
Progress
RAQuantity
320442
Bid Type
Two Packet Bid
Indian Army announces a tender for Fluconazole 50 mg capobliqueTab, Fluconazole infusion 2 mgobliqueml 100 ml bott, Tab Valaciclovir HCL 500 mg, Cefepime 1gm Inj, Tigecycline 50 mg powder for injection, Cefoperazone Sodium 1 gm Inj, Inj Azithromycin 500 mg, Faropenam 300 mg Tab, Inj Doxycycline 100 mg, Gancyclovir 500 mgobliquevial Inj, Inj Fosphenytoin 75 mgobliqueml 2 ml Amp, Topiramate 25 mg Tab, Baclofen 10 mg Tab, Levetiracetam 100 mg oblique ml Syrup obliqueSoln oblique Liquid, Tab Pyridostigmine Bromide ER 180 mg, Prampexole 0point25 mg Tab, Clonazepam 2 mg Tab, Lorazepam 2mg oblique ml 2 ml Inj, Dexamethasone Sodium Phosphate 4point4 mg Equivalent to Dexamethasone Phosphate, Prednisolone 5 mg Tab, Betamethasone 4 mg 1ml Inj, Diclofenac 75mg oblique ml 1 ml Amp Inj, Paracetamol 325 mg PLUS Diclofenac Sodium 50 mg Tab, Paracetamol with cysteine HCL monohydrate Infusion 1000mgoblique100ml, Paracetamol 10 mgobliqueml infusion in 100 ml bottls, Indomethacin 75mg SR Cap in KOLKATA, WEST BENGAL. Quantity: 320442. Submission Deadline: 07-04-2025 15: 00: 00. Last date to apply is approaching fast!
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Fluconazole 50 mg capobliqueTab , Fluconazole infusion 2 mgobliqueml 100 ml bott , Tab Valaciclovir HCL 500 mg , Cefepime 1gm Inj , Tigecycline 50 mg powder for injection , Cefoperazone Sodium 1 gm Inj , Inj Azithromycin 500 mg , Faropenam 300 mg Tab , Inj Doxycycline 100 mg , Gancyclovir 500 mgobliquevial Inj , Inj Fosphenytoin 75 mgobliqueml 2 ml Amp , Topiramate 25 mg Tab , Baclofen 10 mg Tab , Levetiracetam 100 mg oblique ml Syrup obliqueSoln oblique Liquid , Tab Pyridostigmine Bromide ER 180 mg , Prampexole 0point25 mg Tab , Clonazepam 2 mg Tab , Lorazepam 2mg oblique ml 2 ml Inj , Dexamethasone Sodium Phosphate 4point4 mg Equivalent to Dexamethasone Phosphate , Prednisolone 5 mg Tab , Betamethasone 4 mg 1ml Inj , Diclofenac 75mg oblique ml 1 ml Amp Inj , Paracetamol 325 mg PLUS Diclofenac Sodium 50 mg Tab , Paracetamol with cysteine HCL monohydrate Infusion 1000mgoblique100ml , Paracetamol 10 mgobliqueml infusion in 100 ml bottls , Indomethacin 75mg SR Cap
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Fluconazole 50 mg capobliqueTab
Fluconazole 50 mg capobliqueTab
Fluconazole infusion 2 mgobliqueml 100 ml bott
Fluconazole infusion 2 mgobliqueml 100 ml bott
Tab Valaciclovir HCL 500 mg
Tab Valaciclovir HCL 500 mg
Cefepime 1gm Inj
Cefepime 1gm Inj
Tigecycline 50 mg powder for injection
Tigecycline 50 mg powder for injection
Cefoperazone Sodium 1 gm Inj
Cefoperazone Sodium 1 gm Inj
Inj Azithromycin 500 mg
Inj Azithromycin 500 mg
Faropenam 300 mg Tab
Faropenam 300 mg Tab
Inj Doxycycline 100 mg
Inj Doxycycline 100 mg
Gancyclovir 500 mgobliquevial Inj
Gancyclovir 500 mgobliquevial Inj
Inj Fosphenytoin 75 mgobliqueml 2 ml Amp
Inj Fosphenytoin 75 mgobliqueml 2 ml Amp
Topiramate 25 mg Tab
Topiramate 25 mg Tab
Baclofen 10 mg Tab
Baclofen 10 mg Tab
Levetiracetam 100 mg oblique ml Syrup obliqueSoln oblique Liquid
Levetiracetam 100 mg oblique ml Syrup obliqueSoln oblique Liquid
Tab Pyridostigmine Bromide ER 180 mg
Tab Pyridostigmine Bromide ER 180 mg
Prampexole 0point25 mg Tab
Prampexole 0point25 mg Tab
Clonazepam 2 mg Tab
Clonazepam 2 mg Tab
Lorazepam 2mg oblique ml 2 ml Inj
Lorazepam 2mg oblique ml 2 ml Inj
Dexamethasone Sodium Phosphate 4point4 mg Equivalent to Dexamethasone Phosphate
Dexamethasone Sodium Phosphate 4point4 mg Equivalent to Dexamethasone Phosphate 4 mgobliqueml 2 ml Inj
Prednisolone 5 mg Tab
Prednisolone 5 mg Tab
Betamethasone 4 mg 1ml Inj
Betamethasone 4 mg, 1ml Inj
Diclofenac 75mg oblique ml 1 ml Amp Inj
Diclofenac 75mg oblique ml 1 ml Amp Inj
Paracetamol 325 mg PLUS Diclofenac Sodium 50 mg Tab
Paracetamol 325 mg PLUS Diclofenac Sodium 50 mg Tab
Paracetamol with cysteine HCL monohydrate Infusion 1000mgoblique100ml
Paracetamol with cysteine HCL monohydrate Infusion 1000mgoblique100ml
Paracetamol 10 mgobliqueml infusion in 100 ml bottls
Paracetamol 10 mgobliqueml infusion in 100 ml bottls
Indomethacin 75mg SR Cap
Indomethacin 75mg SR Cap
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Fluconazole 50 mg capobliqueTab | Fluconazole 50 mg capobliqueTab | 15,840 | no | consignee2dglp | 30 | |
| 2 | Fluconazole infusion 2 mgobliqueml 100 ml bott | Fluconazole infusion 2 mgobliqueml 100 ml bott | 1,860 | bott | consignee2dglp | 30 | |
| 3 | Tab Valaciclovir HCL 500 mg | Tab Valaciclovir HCL 500 mg | 7,680 | no | consignee2dglp | 30 | |
| 4 | Cefepime 1gm Inj | Cefepime 1gm Inj | 1,470 | no | consignee2dglp | 30 | |
| 5 | Tigecycline 50 mg powder for injection | Tigecycline 50 mg powder for injection | 1,000 | vial | consignee2dglp | 30 | |
| 6 | Cefoperazone Sodium 1 gm Inj | Cefoperazone Sodium 1 gm Inj | 1,900 | amp slace vial | consignee2dglp | 30 | |
| 7 | Inj Azithromycin 500 mg | Inj Azithromycin 500 mg | 1,440 | vial | consignee2dglp | 30 | |
| 8 | Faropenam 300 mg Tab | Faropenam 300 mg Tab | 21,650 | no | consignee2dglp | 30 | |
| 9 | Inj Doxycycline 100 mg | Inj Doxycycline 100 mg | 1,260 | vial | consignee2dglp | 30 | |
| 10 | Gancyclovir 500 mgobliquevial Inj | Gancyclovir 500 mgobliquevial Inj | 460 | vial | consignee2dglp | 30 | |
| 11 | Inj Fosphenytoin 75 mgobliqueml 2 ml Amp | Inj Fosphenytoin 75 mgobliqueml 2 ml Amp | 645 | amp | consignee2dglp | 30 | |
| 12 | Topiramate 25 mg Tab | Topiramate 25 mg Tab | 23,700 | no | consignee2dglp | 30 | |
| 13 | Baclofen 10 mg Tab | Baclofen 10 mg Tab | 33,400 | no | consignee2dglp | 30 | |
| 14 | Levetiracetam 100 mg oblique ml Syrup obliqueSoln oblique Liquid | Levetiracetam 100 mg oblique ml Syrup obliqueSoln oblique Liquid | 2,481 | vial | consignee2dglp | 30 | |
| 15 | Tab Pyridostigmine Bromide ER 180 mg | Tab Pyridostigmine Bromide ER 180 mg | 7,050 | no | consignee2dglp | 30 | |
| 16 | Prampexole 0point25 mg Tab | Prampexole 0point25 mg Tab | 7,080 | no | consignee2dglp | 30 | |
| 17 | Clonazepam 2 mg Tab | Clonazepam 2 mg Tab | 9,120 | no | consignee2dglp | 30 | |
| 18 | Lorazepam 2mg oblique ml 2 ml Inj | Lorazepam 2mg oblique ml 2 ml Inj | 3,675 | amp | consignee2dglp | 30 | |
| 19 | Dexamethasone Sodium Phosphate 4point4 mg Equivalent to Dexamethasone Phosphate | Dexamethasone Sodium Phosphate 4point4 mg Equivalent to Dexamethasone Phosphate 4 mgobliqueml 2 ml Inj | 9,110 | amp slace vial | consignee2dglp | 30 | |
| 20 | Prednisolone 5 mg Tab | Prednisolone 5 mg Tab | 77,376 | no | consignee2dglp | 30 | |
| 21 | Betamethasone 4 mg 1ml Inj | Betamethasone 4 mg, 1ml Inj | 2,585 | vial slace amp | consignee2dglp | 30 | |
| 22 | Diclofenac 75mg oblique ml 1 ml Amp Inj | Diclofenac 75mg oblique ml 1 ml Amp Inj | 3,460 | amp | consignee2dglp | 30 | |
| 23 | Paracetamol 325 mg PLUS Diclofenac Sodium 50 mg Tab | Paracetamol 325 mg PLUS Diclofenac Sodium 50 mg Tab | 36,600 | no | consignee2dglp | 30 | |
| 24 | Paracetamol with cysteine HCL monohydrate Infusion 1000mgoblique100ml | Paracetamol with cysteine HCL monohydrate Infusion 1000mgoblique100ml | 8,250 | bott | consignee2dglp | 30 | |
| 25 | Paracetamol 10 mgobliqueml infusion in 100 ml bottls | Paracetamol 10 mgobliqueml infusion in 100 ml bottls | 4,800 | bott | consignee2dglp | 30 | |
| 26 | Indomethacin 75mg SR Cap | Indomethacin 75mg SR Cap | 36,550 | no | consignee2dglp | 30 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
17-May-2025, 1:00 pm
End
19-May-2025, 1:00 pm
Duration: 48 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 05-04-2025 17:30:55 | |
| 2 | ********** Under PMA | - | 07-04-2025 14:32:13 | |
| 3 | ********** Under PMA | - | 07-04-2025 08:51:40 | |
| 4 | ********** Under PMA | - | 04-04-2025 18:48:46 | |
| 5 | ********** Under PMA | - | 02-04-2025 16:17:33 | |
| 6 | ********** Under PMA | - | 05-04-2025 18:38:54 | |
| 7 | ********** Under PMA | - | 05-04-2025 16:01:39 | |
| 8 | ********** Under PMA | - | 28-03-2025 15:43:24 | |
| 9 | ********** Under PMA | - | 07-04-2025 00:34:42 | |
| 10 | ********** Under PMA | - | 07-04-2025 14:36:51 | |
| 11 | ********** Under PMA | - | 04-04-2025 14:24:07 | |
| 12 | ********** Under PMA | - | 07-04-2025 14:42:48 | |
| 13 | ********** Under PMA | - | 02-04-2025 14:11:23 | |
| 14 | ********** Under PMA | - | 18-03-2025 16:59:33 | |
| 15 | ********** Under PMA | - | 07-04-2025 14:17:18 | |
| 16 | ********** Under PMA | - | 26-03-2025 14:54:11 | |
| 17 | ********** Under PMA | - | 31-03-2025 13:51:32 | |
| 18 | ********** Under PMA | - | 24-03-2025 17:14:38 | |
| 19 | ********** Under PMA | - | 07-04-2025 14:13:38 | |
| 20 | ********** Under PMA | - | 07-04-2025 00:02:22 |
Key insights about WEST BENGAL tender market
The eligibility requirements include being a registered entity, possessing valid licenses to operate in the pharmaceutical sector, and having demonstrated experience in supplying similar products. Bidders must also meet any additional criteria set by the Department of Military Affairs, ensuring that they have the capacity and capability to deliver the specified products.
To comply with the technical specifications, bidders must provide detailed documentation on the products' ingredients, manufacturing processes, and quality control procedures. Additionally, bidders must ensure that their products adhere to the quality standards mandated by health authorities, including any testing criteria for pharmaceutical items outlined in the tender documentation.
An Earnest Money Deposit (EMD) is required as part of the bid submission process, acting as a security measure to ensure commitment from bidders. The specific EMD amount and payment terms will be outlined in the tender documentation. Bidders must comply with these requirements to avoid disqualification from the tender.
The evaluation and selection process will involve a multi-step approach, where submissions are first checked for completeness and adherence to the eligibility criteria. Following this, technical capabilities and financial standings will be assessed based on defined scoring systems. Bidders will be notified of the results of the evaluation and the selection of successful bidders.
MSEs benefit from specific provisions designed to encourage their participation in this tender. These may include relaxed eligibility criteria, support in the bidding process, and prioritization in the awarding of contracts to promote local businesses, aligning with the government's focus on nurturing the growth of small enterprises in procurement initiatives.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS